Truist Financial Corp (TFC) is not a strong buy at this moment for a beginner, long-term investor. While the stock has some positive catalysts like improved financial performance and potential regulatory tailwinds, the technical indicators, options sentiment, and analyst ratings present mixed signals. Additionally, hedge fund selling and a bearish short-term stock trend suggest caution. Given the investor's preference for long-term growth and the lack of strong proprietary trading signals, holding off on purchasing TFC is recommended for now.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 44.971, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key resistance levels are at 45.724 and 46.426, while support levels are at 43.451 and 42.749. The stock is trading near its pivot point of 44.587, suggesting limited upside in the short term.

Improved financial performance in Q4 2025, with revenue up 0.16% YoY, net income up 6.00% YoY, and EPS up 9.78% YoY.
Regulatory tailwinds from the Federal Reserve's proposal to lower capital requirements, which could enhance competitiveness and unlock growth opportunities.
Analyst upgrades from firms like Morgan Stanley and TD Cowen, citing strong capital reserves and potential for increased buybacks.
Hedge funds are aggressively selling, with a 1288.05% increase in selling activity last quarter.
Mixed analyst ratings, including a recent 'Underperform' rating from Jefferies with a $35 price target, citing execution risks and competitive pressures.
Bearish short-term stock trend, with a 90% probability of a -5.37% decline over the next month.
Lack of recent congress trading data or influential insider buying activity.
In Q4 2025, revenue increased to $4.93 billion (up 0.16% YoY), net income rose to $1.29 billion (up 6.00% YoY), and EPS improved to 1.01 (up 9.78% YoY). These figures indicate steady growth, but the gross margin remained flat.
Analyst sentiment is mixed. Recent upgrades from Baird, Morgan Stanley, and TD Cowen highlight strong capital reserves, attractive valuation, and potential for increased buybacks. However, Jefferies initiated coverage with an 'Underperform' rating and a $35 price target, citing execution risks and competitive pressures. Price targets range from $35 to $69, reflecting significant uncertainty.